These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38174960)

  • 61. Nanoscale Covalent Organic Framework with Staggered Stacking of Phthalocyanines for Mitochondria-Targeted Photodynamic Therapy.
    Liu J; Kang DW; Fan Y; Nash GT; Jiang X; Weichselbaum RR; Lin W
    J Am Chem Soc; 2024 Jan; 146(1):849-857. PubMed ID: 38134050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Pt nanoenzyme- and BODIPY-loaded nanoscale covalent organic framework for relieving intratumoural hypoxia to enhance photodynamic therapy.
    Zhang KX; Wang B; Li WY; Song Y; Song T; Li YA; Dong YB
    Dalton Trans; 2024 Jul; 53(27):11242-11246. PubMed ID: 38919991
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antimicrobial photodynamic therapy assessment of three indocyanine green-loaded metal-organic frameworks against Enterococcus faecalis.
    Golmohamadpour A; Bahramian B; Khoobi M; Pourhajibagher M; Barikani HR; Bahador A
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():331-338. PubMed ID: 30077652
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.
    Neelambaran N; Shamjith S; Murali VP; Maiti KK; Joseph J
    ACS Appl Bio Mater; 2023 Dec; 6(12):5776-5788. PubMed ID: 38061031
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sensitization of Hypoxic Tumor to Photodynamic Therapy via Oxygen Self-Supply of Fluorinated Photosensitizers.
    Liu Z; Xue Y; Wu M; Yang G; Lan M; Zhang W
    Biomacromolecules; 2019 Dec; 20(12):4563-4573. PubMed ID: 31710484
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Remodeling extracellular matrix based on functional covalent organic framework to enhance tumor photodynamic therapy.
    Wang SB; Chen ZX; Gao F; Zhang C; Zou MZ; Ye JJ; Zeng X; Zhang XZ
    Biomaterials; 2020 Mar; 234():119772. PubMed ID: 31945618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selenium-Containing Type-I Organic Photosensitizers with Dual Reactive Oxygen Species of Superoxide and Hydroxyl Radicals as Switch-Hitter for Photodynamic Therapy.
    Wang H; Qin T; Wang W; Zhou X; Lin F; Liang G; Yang Z; Chi Z; Tang BZ
    Adv Sci (Weinh); 2023 Aug; 10(24):e2301902. PubMed ID: 37357144
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BODIPY-Based Photothermal Agents with Excellent Phototoxic Indices for Cancer Treatment.
    Schneider L; Kalt M; Koch S; Sithamparanathan S; Villiger V; Mattiat J; Kradolfer F; Slyshkina E; Luber S; Bonmarin M; Maake C; Spingler B
    J Am Chem Soc; 2023 Mar; 145(8):4534-4544. PubMed ID: 36780327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
    Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
    Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor homing-penetrating and nanoenzyme-augmented 2D phototheranostics against hypoxic solid tumors.
    Wu C; Zhang Y; Wei X; Li N; Huang H; Xie Z; Zhang H; Yang G; Li M; Li T; Yang H; Li S; Qin X; Liu Y
    Acta Biomater; 2022 Sep; 150():391-401. PubMed ID: 35917909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
    Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
    Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxygen Self-Supplying Nanotherapeutic for Mitigation of Tissue Hypoxia and Enhanced Photodynamic Therapy of Bacterial Keratitis.
    Bai Y; Hu Y; Gao Y; Wei X; Li J; Zhang Y; Wu Z; Zhang X
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33790-33801. PubMed ID: 34254513
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multifunctional protein-based self-assembled nanoplatform: overcoming hypoxic tumor microenvironment for enhanced imaging-guided photodynamic therapy.
    Li M; Cheng Z; Liu H; Dou K; Xiao H; Zhao L; Yu F
    Biomater Sci; 2023 Oct; 11(20):6881-6893. PubMed ID: 37647018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Novel Boron Dipyrromethene-Erlotinib Conjugate for Precise Photodynamic Therapy against Liver Cancer.
    Wu W; Luo C; Zhu C; Cai Z; Liu J
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928126
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor-Activated and Metal-Organic Framework Assisted Self-Assembly of Organic Photosensitizers.
    Wang Y; Shi L; Ma D; Xu S; Wu W; Xu L; Panahandeh-Fard M; Zhu X; Wang B; Liu B
    ACS Nano; 2020 Oct; 14(10):13056-13068. PubMed ID: 33016697
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Engineering Diselenide-IR780 Homodimeric Nanoassemblies with Enhanced Photodynamic and Immunotherapeutic Effects for Triple-Negative Breast Cancer Treatment.
    Xue Y; Chen K; Chen Y; Liu Y; Tang J; Zhang X; Liu J
    ACS Nano; 2023 Nov; 17(22):22553-22570. PubMed ID: 37943026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers.
    Ma S; Zhou J; Zhang Y; Yang B; He Y; Tian C; Xu X; Gu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(8):7731-7742. PubMed ID: 30694643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A promising strategy for synergistic cancer therapy by integrating a photosensitizer into a hypoxia-activated prodrug.
    Yang DC; Yang XZ; Luo CM; Wen LF; Liu JY; Lin Z
    Eur J Med Chem; 2022 Dec; 243():114749. PubMed ID: 36115207
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Good Steel Used in the Blade: Well-Tailored Type-I Photosensitizers with Aggregation-Induced Emission Characteristics for Precise Nuclear Targeting Photodynamic Therapy.
    Kang M; Zhang Z; Xu W; Wen H; Zhu W; Wu Q; Wu H; Gong J; Wang Z; Wang D; Tang BZ
    Adv Sci (Weinh); 2021 Jul; 8(14):e2100524. PubMed ID: 34021726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amphiphilic Fullerene-BODIPY Photosensitizers for Targeted Photodynamic Therapy.
    Gündüz EÖ; Gedik ME; Günaydın G; Okutan E
    ChemMedChem; 2022 Mar; 17(6):e202100693. PubMed ID: 34859597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.